Estevan Kiernan | Associate Director, Emerging Clinical Applications-Oncology
Illumina

Estevan Kiernan has worked in infectious disease, genetic disease and oncology molecular diagnostics 15+ years at leading biotech companies including Thermo Fisher/Life Technologies and Abbott. For the Last 7 years he has worked at Illumina to identify future clinical applications and work globally with medical societies and private/public partnerships to lower the barriers for identified applications (ex MRD, Screening, CGP, TMB, HRD harmonization, WGS in Heme). He is currently the chair of multiple working groups within BloodPAC and GUIDE.MRD consortium on implementation, market access and patient accessibility on ctDNA initiatives as well as managing ongoing relationships/projects with multiple medical societies including AMP,FOCR,NCCN, AACR and CAP.